LAUSANNE, Switzerland, Feb 8, 2022 – (亚太商讯 via SEAPRWire.com) – Oculis S.A.（“Oculis”）为一家后期临床生物医药公司，专注于开发创新性眼…
LAUSANNE, Switzerland, Feb 8, 2022 – (ACN Newswire via SEAPRWire.com) – Oculis S.A. (“Oculis”), a late-stage biopharmaceutical company focused on developing transformative ophthalmic treatments to…
LAUSANNE, Switzerland, Jan 5, 2022 – (亚太商讯 via SEAPRWire.com) – Oculis S.A.（「Oculis」）为一家临床后期生物医药公司，专注于开发革命性眼…
LAUSANNE, Switzerland, Jan 5, 2022 – (ACN Newswire via SEAPRWire.com) – Oculis S.A. (“Oculis”), a late-stage biopharmaceutical company focused on developing transformative ophthalmic treatments to…